ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer

ClinicalTrials.gov ID: NCT01839487

Public ClinicalTrials.gov record NCT01839487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 2:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Multicenter Study of PEGPH20 (PEGylated Recombinant Human Hyaluronidase) Combined With Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Previously Untreated Pancreatic Cancer

Study identification

NCT ID
NCT01839487
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Halozyme Therapeutics
Industry
Enrollment
279 participants

Conditions and interventions

Interventions

  • Dexamethasone Drug
  • Enoxaparin Drug
  • Gemcitabine Drug
  • Nab-paclitaxel Drug
  • PEGPH20 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 13, 2013
Primary completion
Apr 30, 2018
Completion
Sep 25, 2018
Last update posted
Jul 19, 2020

2013 – 2018

United States locations

U.S. sites
51
U.S. states
26
U.S. cities
48
Facility City State ZIP Site status
Alabama Oncology Birmingham Alabama 35213
University of South Alabama Mitchell Cancer Institute Mobile Alabama 36604
Banner MD Anderson Cancer Center Gilbert Arizona 85234
Mayo Clinic - Scottsdale Scottsdale Arizona 85259
Arizona Oncology Associates, PC Tucson Arizona 85704
Highlands Oncology Group Fayetteville Arkansas 72703
Providence St Joseph Medical Center Burbank California 91505
Scripps Cancer Center La Jolla California 92037
UCSD - Moore's Cancer Center La Jolla California 92093
Cedars-Sinai Medical Center Los Angeles California 90048
University of California Medical Center Orange California 92868
Pacific Hematology Oncology Associates San Francisco California 94115
Saint Helena Hospital St. Helena California 94574
The Oncology Institute of Hope and Innovation Whittier California 90603
University of Colorado Cancer Center Aurora Colorado 80045
Rocky Mountain Cancer Center Denver Colorado 80218
Stamford Hospital Stamford Connecticut 06902
Georgetown University Medical Center Washington D.C. District of Columbia 20007
University of Miami, Sylvester comprehensive Cancer Center Miami Florida 33136
H. Lee Moffit Cancer Center Tampa Florida 33612
Piedmont Hospital Atlanta Georgia 30318
Loyola University Medical Center Maywood Illinois 60153
Norton Cancer Institute - Norton HealthCare Pavilion Louisville Kentucky 40202
Johns Hopkins University Hospital Baltimore Maryland 21231
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Lahey Clinic Burlington Massachusetts 01805
University of Mass Medical School Worcester Massachusetts 01655
University of Michigan Ann Arbor Michigan 48109
Virginia Piper Cancer Institute Minneapolis Minnesota 55407
Unniversity of Minnesota Minneapolis Minnesota 55455
Research Medical Center Kansas City Missouri 64132
Washington University School of Medicine St Louis Missouri 63110
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169
St. Joseph's Regional Medical Center Paterson New Jersey 07503
Roswell Park Cancer Institute Buffalo New York 14263
North Shore Long Island Jewish Health System Lake Success New York 11042
Mount Sinai Medical Center New York New York 10029
Columbia University Medical Center New York New York 10032
University of Rochester Rochester New York 14642
Gabrail Cancer Center Canton Ohio 44718
University of Oklahoma Health Science Center Oklahoma City Oklahoma 73104
UPMC Cancer Center Pittsburgh Pennsylvania 15213
Greenville Health System Greenville South Carolina 29605
Texas Oncology - Baylor Dallas Texas 75246
Cancer Care Centers of South Texas New Braunfels Texas 78130
Texas Oncology Tyler Texas 75702
Columbia Basin Hematology and Oncology Kennewick Washington 99336
Seattle Cancer Care Alliance Seattle Washington 98109
NorthWest Medical Specialties, PLLC Tacoma Washington 98405
University of Wisconsin Hospitals and Clinics Madison Wisconsin 53792
Froedtert Hospital, Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01839487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2020 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01839487 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →